Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?

被引:1212
作者
Johnson, RJ
Kang, DH
Feig, D
Kivlighn, S
Kanellis, J
Watanabe, S
Tuttle, KR
Rodriguez-Iturbe, B
Herrera-Acosta, J
Mazzali, M
机构
[1] Baylor Coll Med, Div Nephrol, Houston, TX 77030 USA
[2] Baylor Coll Med, Texas Childrens Hosp, Houston, TX 77030 USA
[3] Merck & Co Inc, West Point, PA USA
[4] Heart Inst Spokane, Spokane, WA USA
[5] Univ Hosp, Maracaibo, Venezuela
[6] Univ Zulia, Maracaibo 4011, Venezuela
[7] Inst Cardiol, Mexico City, DF, Mexico
关键词
antioxidants; hypertension; essential; cardiovascular diseases; renin-angiotensin system; vascular diseases; renal disease;
D O I
10.1161/01.HYP.0000069700.62727.C5
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Hyperuricemia is associated with hypertension, vascular disease, renal disease, and cardiovascular events. In this report, we review the epidemiologic evidence and potential mechanisms for this association. We also summarize experimental studies that demonstrate that uric acid is not inert but may have both beneficial functions ( acting as an antioxidant) as well as detrimental actions ( to stimulate vascular smooth muscle cell proliferation and induce endothelial dysfunction). A recently developed experimental model of mild hyperuricemia also provides the first provocative evidence that uric acid may have a pathogenic role in the development of hypertension, vascular disease, and renal disease. Thus, it is time to reevaluate the role of uric acid as a risk factor for cardiovascular disease and hypertension and to design human studies to address this controversy.
引用
收藏
页码:1183 / 1190
页数:8
相关论文
共 103 条
  • [1] GOUT AND CORONARY HEART-DISEASE - THE FRAMINGHAM-STUDY
    ABBOTT, RD
    BRAND, FN
    KANNEL, WB
    CASTELLI, WP
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1988, 41 (03) : 237 - 242
  • [2] Ascorbate prevents prooxidant effects of urate in oxidation of human low density lipoprotein
    Abuja, PM
    [J]. FEBS LETTERS, 1999, 446 (2-3) : 305 - 308
  • [3] Serum uric acid and cardiovascular events in successfully treated hypertensive patients
    Alderman, MH
    Cohen, H
    Madhavan, S
    Kivlighn, S
    [J]. HYPERTENSION, 1999, 34 (01) : 144 - 150
  • [4] ALLARD C, 1973, CAN MED ASSOC J, V109, P986
  • [5] URIC-ACID PROVIDES AN ANTIOXIDANT DEFENSE IN HUMANS AGAINST OXIDANT-CAUSED AND RADICAL-CAUSED AGING AND CANCER - A HYPOTHESIS
    AMES, BN
    CATHCART, R
    SCHWIERS, E
    HOCHSTEIN, P
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (11): : 6858 - 6862
  • [6] [Anonymous], 1976, J CHRON DIS, V29, P557
  • [7] [Anonymous], 1985, PREV MED, V14, P312
  • [8] [Anonymous], 2000, BRIT J CLIN PHARMACO
  • [9] REQUIEM FOR GOUTY NEPHROPATHY
    BECK, LH
    HARRINGTON, JT
    KASSIRER, JP
    PERRONE, R
    MADIAS, NE
    STROM, J
    KURTIN, P
    CANZANELLO, V
    [J]. KIDNEY INTERNATIONAL, 1986, 30 (02) : 280 - 287
  • [10] BENGTSSON C, 1988, ACTA MED SCAND, V224, P549